NDC 68071-2240-01 - CARBIDOPA AND LEVODOPA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-2240
- Requested NDC
- 68071-2240-01
- Package NDCs from labels
- 68071-2240-1, 68071-2240-01
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Effective date
- 2024-07-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carbidopa and Levodopa Tablets, USP | NuCare Pharmaceuticals,Inc. | 2024-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-2240-1 | CARBIDOPA AND LEVODOPA | 100 in 1 BOTTLE | TABLET | 100 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-2240 | CARBIDOPA AND LEVODOPA TABLET [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240719_ad2ab0c4-188b-f025-e053-2a95a90a2816.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Mylan Pharmaceuticals Inc. | aa5028d6-fd0a-4cf1-b708-c93bb2a7c76a | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | b29e58f0-67b1-4036-a4a8-4915a8c13cdf | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | beedd327-bbc5-4f17-838a-4e72bf0867f0 | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 57688b2c-7be0-4e73-9b4f-7ec3b5dc1c37 | 2026-04-24 | Warnings, Adverse reactions | 197445 MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 9ac804f1-7e15-48bc-8ae9-25181a629dd4 | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Coupler LLC | 500f0cdb-10e1-9545-e063-6394a90a3ad1 | 2026-04-22 | Warnings, Adverse reactions | 197445 MNX7R8C5VO 46627O600J |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Cardinal Health 107, LLC | 19d853e2-b8bd-490e-b8d2-b38bec68a139 | 2026-04-16 | Warnings, Adverse reactions | 197445 197444 MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Aurobindo Pharma Limited | 4ced8a05-27ac-463f-b331-387e473fdaa1 | 2026-04-09 | Warnings, Adverse reactions | 197445 197443 197444 MNX7R8C5VO 46627O600J |
| CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2f8e82d7-6baf-456a-b8c3-4fda6e317902 | 2026-04-08 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa, Levodopa and Entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Macleods Pharmaceuticals Limited | f0d9d7a8-1d06-4119-b2bc-42b3ec08d45b | 2026-04-08 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | XLCare Pharmaceuticals, Inc. | 0c630a24-dc51-4601-a5d6-2f9e397a0449 | 2026-04-03 | Warnings, Adverse reactions | 197445 197443 197444 MNX7R8C5VO 46627O600J |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Camber Pharmaceuticals, Inc. | 770ba054-fec4-4833-8096-85c3ce3ae830 | 2026-04-01 | Warnings, Adverse reactions | 197445 197443 197444 MNX7R8C5VO 46627O600J |
| carbidopa, levodopa and entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Alembic Pharmaceuticals Inc. | 9d4e886e-edec-471d-b619-bf4828a6b7ce | 2026-03-31 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Alembic Pharmaceuticals Inc. | ac18e5fa-e2ee-4aa5-8d0f-94b63a076e66 | 2026-03-30 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals NY LLC | 0eb24333-3c11-41dd-888d-3a30d3c9d188 | 2026-03-30 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| RYTARY | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals LLC | 6c1f7cd4-de56-45c1-a734-5e77b4aeb6f7 | 2026-03-26 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa, Levodopa, and Entacapone | CARBIDOPA, LEVODOPA, AND ENTACAPONE | Sandoz Inc | 9c16c0e0-3b97-486b-b7d5-579f5853e2c5 | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Duopa | CARBIDOPA AND LEVODOPA | AbbVie Inc. | 7066d371-dc6a-0d6f-7bed-e5dd4ee912da | 2026-03-19 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.